Comment
doi: 10.1038/nrurol.2014.139.
Epub 2014 Jun 17.
Prostate cancer: enzalutamide PREVAILs
- PMID: 24934449
- DOI: 10.1038/nrurol.2014.139
Item in Clipboard
Comment
Prostate cancer: enzalutamide PREVAILs
Nat Rev Urol.
2014 Jul.
No abstract available
Comment on
-
Enzalutamide in metastatic prostate cancer before chemotherapy.N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
Similar articles
-
Enzalutamide in metastatic prostate cancer before chemotherapy.N Engl J Med. 2014 Oct 30;371(18):1755. doi: 10.1056/NEJMc1410239. N Engl J Med. 2014. PMID: 25354112 No abstract available.
-
Enzalutamide in metastatic prostate cancer before chemotherapy.N Engl J Med. 2014 Oct 30;371(18):1755-6. doi: 10.1056/NEJMc1410239. N Engl J Med. 2014. PMID: 25354111 No abstract available.
-
Words of wisdom. Re: Enzalutamide in metastatic prostate cancer before chemotherapy.Eur Urol. 2015 Jan;67(1):174. doi: 10.1016/j.eururo.2014.09.047. Epub 2014 Nov 25. Eur Urol. 2015. PMID: 25528395 No abstract available.
-
The evolving role of enzalutamide on the treatment of prostate cancer.Future Oncol. 2016 Mar;12(5):607-16. doi: 10.2217/fon.15.351. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26839021 Free PMC article. Review.
-
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated: © NICE (2016) Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated.BJU Int. 2017 Aug;120(2):168-184. doi: 10.1111/bju.13936. BJU Int. 2017. PMID: 28719114 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
